HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development.

Saved in:
Bibliographic Details
Title: HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development.
Authors: Elnaggar JH; School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, United States.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Huynh VO; School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, United States., Lin D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hillman RT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Cancer Prevention Research Institute of Texas Scholar in Cancer Research, Austin, TX, United States., Abana CO; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., El Alam MB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Tomasic KC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Karpinets TV; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kouzy R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Phan JL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wargo J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Holliday EB; Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Das P; Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mezzari MP; The Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States., Ajami NJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lynn EJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Minsky BD; Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Morris VK; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Milbourne A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Messick CA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Klopp AH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Taniguchi CM; Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Schmeler KM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Colbert LE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Source: Frontiers in immunology [Front Immunol] 2023 Mar 29; Vol. 14, pp. 1051431. Date of Electronic Publication: 2023 Mar 29 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2023.1051431